The search result of literature (PMID: 28859616) on HBV-associated Chronic hepatitis B


ID PMID Mutation Gene/Protein/Region Description Detail
1 28859616 P120S
S
G
S
I
C
View
2 28859616 P120T
S
G
S
I
C
View
3 28859616 I126A
S
G
S
I
C
View
4 28859616 I126N
S
G
S
I
C
View
5 28859616 I126I
S
G
S
I
C
View
6 28859616 I126S
S
G
S
I
C
View
7 28859616 T126A
S
G
S
I
C
View
8 28859616 T126N
S
G
S
I
C
View
9 28859616 T126I
S
G
S
I
C
View
10 28859616 T126S
S
G
S
I
C
View
11 28859616 M133L
S
G
S
I
C
View
12 28859616 M133T
S
G
S
I
C
View
13 28859616 G145R
S
G
S
I
C
View
14 28859616 A1762T
BCP
G
S
C
View
15 28859616 G1764A
BCP
G
S
C
View
16 28859616 G1896A
PreC
G
S
C
View
17 28859616 G1764T
BCP
G
S
C
View
18 28859616 A2962G
PreS1
G
S
C
View
19 28859616 C2964A
PreS1
G
S
C
View
20 28859616 C3026A
PreS1
G
S
C
View
21 28859616 C3026T
PreS1
G
S
C
View
22 28859616 T53C
PreS2
G
S
C
View
23 28859616 A162G
PreS2
G
S
C
View
24 28859616 T531C
PreS2
G
S
C
View
25 28859616 T531G
PreS2
G
S
C
View
26 28859616 A706C
S
G
S
C
View
27 28859616 T766A
S
G
S
C
View
28 28859616 N38E
PreS1
G
S
C
View
29 28859616 N38K
PreS1
G
S
C
View
30 28859616 A60V
PreS1
G
S
C
View
31 28859616 A60E
PreS1
G
S
C
View
32 28859616 M1V
PreS2
G
S
C
View
33 28859616 M1T
PreS2
G
S
C
View
34 28859616 M1I
PreS2
G
S
C
View
35 28859616 F22I
PreS2
G
S
C
View
36 28859616 N3S
PreS2
G
S
C
View
37 28859616 L126T
PreS2
G
S
C
View
38 28859616 L126S
PreS2
G
S
C
View
39 28859616 V184A
S
G
S
C
View
40 28859616 S204R
S
G
S
C
View
41 28859616 C1653T
BCP
G
S
C
View
42 28859616 T1753C
BCP
G
S
C
View
43 28859616 G1757A
BCP
G
S
C
View
44 28859616 C1766G
BCP
G
S
C
View
45 28859616 T1768A
BCP
G
S
C
View
46 28859616 G1899A
PreC
G
S
C
View
47 28859616 A2159G
C
G
S
C
View
48 28859616 A2189C
C
G
S
C
View
49 28859616 G2203A
C
G
S
C
View
50 28859616 G2203T
C
G
S
C
View
51 28859616 F22L
PreS2
G
S
C
View
Contents
Description
Table Description Column Note
D
Drugs mentioned in the relevant literature.
G
Genotypes/subtypes mentioned in the relevant literature.
R
Reference genomes mentioned in the relevant literature.
S
Viral sequences mentioned in the relevant literature.
C
Geographical distribution of the source mentioned in the relevant literature.
CI
Clinical information is available in the relevant literature.
I
This mutation is related to the immune escape.